Managing Myotonic Dystrophy Type 1 Complicated by Metabolic Syndrome

Gianluca Pagnoni, Ashraf Nassar, Francesca Grossule, Matteo Paolini, Arianna Maini, Anna Vittoria Mattioli, Giuseppe Boriani, Francesca Coppi · 2024

Read Managing Myotonic Dystrophy Type 1 Complicated by Metabolic Syndrome by Gianluca Pagnoni, Ashraf Nassar, Francesca Grossule, Matteo Paolini, Arianna Maini, Anna Vittoria Mattioli, Giuseppe Boriani, Francesca Coppi (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11646923.txt.

Description

Myotonic dystrophy type 1 is the most common form of muscular dystrophy in adults, caused by a repeated stretch of DNA in one gene. Gianluca Pagnoni and co-authors present a case from 2024 in which the disease came paired with metabolic syndrome, the cluster of insulin resistance and blood fat problems. Muscle weakness leads to a sedentary life, which makes that pairing more likely.

The patient could not tolerate the standard statin drugs, so the team turned to a newer mix: PCSK9 inhibitors, ezetimibe, and bempedoic acid. The case shows how that mix can manage blood fats when first-line drugs fail. The authors stress that care for such patients must be tailored, since no set guidance exists for this exact pairing of diseases.

Catalog record

CREATORGianluca Pagnoni, Ashraf Nassar, Francesca Grossule, Matteo Paolini, Arianna Maini, Anna Vittoria Mattioli, Giuseppe Boriani, Francesca Coppi
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE23 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11646923

Browse the full library · About the Tower of Babel